September 23, 2019
- Manual of Policies and Procedures (MAPP) 6701.1 Procedures for DMEPA Intra-Center Consult to DMPP on Patient-Oriented Labeling Submitted with Human Factors Validation Study Protocols (PDF)
- Amyotrophic Lateral Sclerosis: Developing Drugs for Treatment Guidance for Industry
- FDA Drug Safety Podcast: FDA warns about rare but severe lung inflammation with Ibrance, Kisqali, and Verzenio for breast cancer
- FDA Drug Shortages
- Buspirone HCl Tablets (Updated - Currently in Shortage)
- Carisoprodol Tablets, USP (Updated - Currently in Shortage)
- Dextrose 50% Injection (Updated - Resolved)
- Erythromycin Ophthalmic Ointment (Updated - Currently in Shortage)
- Ketorolac Tromethamine Injection (Updated - Currently in Shortage)
- Labetalol Hydrochloride Injection (Updated - Currently in Shortage)
- Metoprolol Tartrate Injection, USP (Updated - Currently in Shortage)
- Drug Trials Snapshots: NOURIANZ
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- Drugs@FDA Data Files (updated)
- National Drug Code Directory (updated)
- Wholesale Distributor Verification Requirement for Saleable Returned Drug Product—Compliance Policy Guidance for Industry
.png)
No hay comentarios:
Publicar un comentario